Cranial Surgery News
-
LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures
LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. The clinical use of this product is expected ...
By RevBio Inc.
-
RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology
RevBio, Inc., announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of vertebral compression fractures with its patented bone adhesive technology known as Tetranite®. Because the osteoconductive bone adhesive is ...
By RevBio Inc.
-
Navient image guided navigation system receives Health Canada approval
ClaroNav Kolahi Inc (CKI) is pleased to announce that it has received Health Canada approval for its Navient ENT and Navient Cranial as Class III medical devices. Previously both devices had been approved as Class II devices. “Navient is one of the very few image guided navigation systems approved by Health Canada as a Class III device. Upgrading our license to a higher class demonstrates ...
By ClaroNav
-
SeaSpine Announces CE Mark Certification of 7D Surgical Cranial Module and Percutaneous Spine Module for Minimally Invasive Spine Surgery
CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH™ Navigation System. This achievement expands the ...
By 7D Surgical
-
Galaxy Medical Releases ECLIPSE-AF Remapping Data at Stanford Biodesign Retreat and Update on System Interoperability
SAN CARLOS, California, July 28, 2021 — Galaxy Medical announced today that the ECLIPSE-AF 90-day remapping data, presented at the Stanford BioDesign New Arrhythmia Technologies retreat, demonstrated durable lesions and chronic pulmonary vein isolation (PVI). Also, the company has recently treated patients in the same study using CE-Marked catheters and mapping systems from Boston ...
-
First Patient Treated in Polyganics’ ENCASE II Trial for Innovative Dura Sealant Patch, LIQOSEAL
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patient in its ENCASE II clinical trial for LIQOSEAL. LIQOSEAL is an easy-to-use, synthetic dura sealant patch indicated for use as an adjunct to standard methods of cranial dural repair, to provide watertight closure of the dura mater and ...
-
SeaSpine Announces Closing of 7D Surgical Acquisition
CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical. 7D Surgical is a Toronto-based company that develops advanced optical technologies and machine vision-based ...
By 7D Surgical
-
Veteran-Owned Company, in Partnership With Synaptive Medical, Awarded Medical Equipment ECAT Contract for Modus V™
Fidelis Sustainability Distribution, a veteran-owned company, has been awarded a Medical Equipment ECAT contract by the Defense Logistics Agency valued at $45,000,000 USD over 5 years. The ECAT contract is an online source (electronic catalog) for Robotic Assisted Surgery and other OR related products and acts as one of the preferred purchasing sources for the Department of Defense (DoD) and the ...
-
Synaptive Medical Announces Close of $17M Preferred Share Financing
Synaptive Medical, a leader in automation and robotics, announced today it has completed a sale of preferred equity totaling $17,000,000 USD. The investment was made by Sensegain Group, a leading asset management firm in China. Ms. Jing Yang, Board Member & Senior Partner of Sensegain, will join Synaptive’s Board of Directors. Sensegain Group is headquartered in Beijing with multiple ...
-
Balt Receives IDE Approval From the FDA to Begin the STEM Trial
Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma. Chronic Sub-Dural Hematoma (cSDH) is a common disease affecting primarily older adults. A recent Veterans Affairs (VA) study of cSDH ...
-
Endomedix, Inc. to Present at Upcoming Society For Biomaterials 2019 Annual Meeting
Endomedix, Inc., a developer of unique biosurgical products based on natural biopolymer systems, today announced it will provide the first public presentation of its work at a scientific meeting. The 2019 Annual Meeting is scheduled for April 3-6 in Seattle, Washington. The presentation will provide data and descriptions of the performance of its patented hydrogel biomaterial in a series of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you